1Pitt B, Zannad F, Remme WJ, et al. For the randomized Aldactone Evaluation Study investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med, 1999,341:709 - 711
2Delyani JA. Anti-aldosterone therapy in the treatment of heart failure new thoughts on an old hormone. Exp Qpin Invest Drugs, 1998,7:753- 759
3Duprez DA, Bauwens FR, De Buyzere ML, et al.Influence of blood pressure and aldosterone on left ventriculasr hypertrophy in moderate essential hypertention. Am J Cardiol, 1993,71:17A - 20A
4Swedberg K, Eneroth P, Kjekshus J, et al. For the CONSENUS Trail Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation,1999,82:1730 - 1736
5Brilla CG, Matsubara LS, Weber KT. Antifibrotic effect of spironalactone in preventing myocardial fibrosis in systemic arterial hypertention. Am J Cardiol, 1993,71:12A - 16A
6Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium:fibrosis and renin-angiotensin-aldosterone system. Circulation, 1991,83:1849- 1865
7Brunner HR, Laragg JH, Newton MA, et al. Essential hypertention: rennin and aldosterone, heart attack and stroke. N Engl J Med, 1972,286:441 -449
8Duprez D. Eur Heart J Supplements, 2000; 2 (suppl A) : A21-A24
9Ferrari R. Eur Heart J supplements, 2000 ; 2 (Suppl A) : A6-A12
8American Hear Association. ACC/AHA 2008 Guidelines forthe management of adults with congenital heart disease[J]. Journal of the American College of Cardiology, 200S, 23 (52) 143 - 263.
9Swedberg K,Cleland J,Dargie H,e* al. Guidelines for the di-agnosis and treatment of chronic heart failure:execctive sum- mary ( update 2005) : The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology[J]. Eur Heart J ,2005,26:1115- 1143.
10Effects of enalap ril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enal- april Survival Study (CONSENSUS). The CONSENSUS Trial Study Group[J]. N Engl J Med,1987,316:1429- 1435.
